clinical trials

BrainVectis gains approval for Phase I/II Huntington’s gene therapy trial
Clinical Trials Arena
Wed, 08/24/22 - 10:46 pm
AskBio
BrainVectis
clinical trials
Huntington's disease
Inhibikase doses first subject in Phase IIa Parkinson’s treatment trial
Clinical Trials Arena
Wed, 08/24/22 - 10:38 am
Inhibikase Therapeutics
clinical trials
Parkinson's Disease
IkT-148009
Foghorn Therapeutics Provides Further Update on FHD-286 Phase I Study in Relapsed/Refractory AML/MDS
BioSpace
Tue, 08/23/22 - 10:35 am
Foghorn Therapeutics
FHD-286
AML
MDS
FDA
clinical trials
As Russia’s clinical trials sector falls, Ukraine rebuilds
Clinical Trials Arena
Tue, 08/23/22 - 10:30 am
Russia
Ukraine
clinical trials
Vaderis Forms to Tackle Vascular Malformations with Novartis Vet at the Helm
BioSpace
Mon, 08/22/22 - 10:24 am
Vaderis
Novartis
vascular malformations
clinical trials
VAD044
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes
Yahoo Finance
Mon, 08/22/22 - 10:00 am
Novo Nordisk
clinical trials
CagriSema
semaglutide
diabetes
type 2 diabetes
Maplight concludes Phase I trial of schizophrenia and dyskinesia therapy
Clinical Trials Arena
Fri, 08/19/22 - 10:38 am
Maplight Therapeutics
clinical trials
ML-007
schizophrenia
dyskinesia
CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial
Clinical Trials Arena
Fri, 08/19/22 - 10:31 am
CureVac
clinical trials
MRNA
CV0501
boosters
COVID-19
Pfizer discontinues development of dilated cardiomyopathy drug emprumapimod
Clinical Trials Arena
Thu, 08/18/22 - 11:14 pm
Pfizer
dilated cardiomyopathy
clinical trials
emprumapimod
Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial
BioSpace
Thu, 08/18/22 - 12:45 pm
Jazz Pharma
Epidiolex
clinical trials
pediatrics
epilepsy
cannabindoids
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Fierce Biotech
Thu, 08/18/22 - 12:40 pm
Astellas
menopause
FDA
clinical trials
Asia
fezolinetant
hot flashes
CSL reports Phase III data for garadacimab to treat hereditary angioedema
Clinical Trials Arena
Thu, 08/18/22 - 12:30 pm
CSL
clinical trials
garadacimab
HAE
hereditary angiodema
FDA lifts partial hold on Curis' lymphoma study — shares spike
Endpoints
Thu, 08/18/22 - 11:08 am
FDA
Curis
lymphoma
clinical trials
emavusertib
Blueprint drug succeeds in rare disease study important to its market prospects
BioPharma Dive
Wed, 08/17/22 - 10:55 am
Blueprint Medicines
systemic mastocytosis
clinical trials
Ayvakit
Sanofi scraps oral SERD strategy after 2nd failure in breast cancer
Fierce Biotech
Wed, 08/17/22 - 10:50 am
Sanofi
SERD
breast cancer
clinical trials
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
Endpoints
Tue, 08/16/22 - 11:59 pm
AbbVie
CD47
SEC
clinical trials
I-Mab
Zai Lab
Ventyx touts early data for potential rival to Bristol Myers psoriasis drug
BioPharma Dive
Tue, 08/16/22 - 12:22 pm
Ventyx Biosciences
clinical trials
Bristol Myers Squibb
psoriasis
VTX958
deucravacitinib
Genprex to progress Phase I/II trial of non-small cell lung cancer therapy
Clinical Trials Arena
Tue, 08/16/22 - 12:15 pm
Genprex
clinical trials
Reqorsa
AstraZeneca
Tagrisso
non-small cell lung cancer
Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial
Clinical Trials Arena
Tue, 08/16/22 - 11:12 am
Anixa Biosciences
clinical trials
CAR-T
ovarian cancer
Clene claims its PhII MS trial, half its intended size, cleared the primary goal. But can the biotech afford PhIII?
Endpoints
Mon, 08/15/22 - 10:23 am
Clene Nanomedicine
multiple sclerosis
MS
clinical trials

Pages